Prohibiting certain health insurers from requiring cost-sharing for nonopioid prescription drugs or providing less favorable coverage for such drug than that for opioid or narcotic prescription drugs for the treatment of pain.
Providing price limits and other requirements for health benefits covering prescription insulin drugs and establishing the insulin affordability program for the uninsured.
Requiring a prescriber discuss the risks of certain addictive controlled substances and alternatives to such substances with a patient before issuing a prescription for such subtances.
House Substitute for SB 233 by Committee on Health and Human Services - Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare providers from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare providers for providing such treatments, requiring professional discipline against a healthcare provider who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Enacting the forbidding abuse child transitions act, restricting use of state funds to promote gender transitioning, prohibiting healthcare professionals from treating children whose gender identity is inconsistent with the child's sex, authorizing a civil cause of action against healthcare professionals for providing such treatments, authorizing professional discipline against a physician who performs such treatment, prohibiting professional liability insurance from covering damages for healthcare providers that provide gender transition treatment to children and adding violation of the act to the definition of unprofessional conduct for physicians and nurses.
Enacting the "Defense of affordable prescriptions act" to prohibit certain discriminatory actions related to reimbursement of entities participating in the federal 340B drug pricing program.
Requiring that certain health insurance plans impose no-cost sharing requirement on insured individuals for diagnostic breast examinations for breast cancer.
House Substitute for SB 287 by Committee on Health and Human Services - Prohibiting a healthcare provider from administering medication, diagnostic tests or conducting ongoing behavioral health treatments to a minor in a school facility without parental consent, enacting the no patient left alone act to require medical care facilities to allow in-person visitation in certain circumstances, expanding licensure of rural emergency hospitals that meet criteria between January 2015 and December 2020 and authorizing emergency medical responders to distribute non prescription over-the-counter medications.